A MAN who was paralysed by a rare autoimmune disorder stunned doctors by learning to walk again after a world-first plasma ...

Real-world evidence study shows ANX005 improves muscle strength and functional outcomes in Guillain-Barré Syndrome compared to current treatments. Potential regulatory concerns may arise if the FDA ...

Patients with Guillain-Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.

Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...

Udaipur: A five-year-old girl from Rajsamand district has made a full recovery from Guillain-Barré Syndrome (GBS), a rare and ...

KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...

Guillain-Barré syndrome (GBS) is an acute, immune-mediated neuropathy characterised by rapidly progressive limb weakness and areflexia. Diagnostic evaluation begins with a detailed clinical history, ...

Sufjan Stevens has revealed that he is currently undergoing intensive treatment for Guillain-Barré syndrome—a rare auto-immune disorder in which the body’s immune system attacks the nerves. In a post ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...